5-ASA Therapy: The Cornerstone of Management in Mild-To-Moderate Ulcerative Colitis

Summary: <p>CME credits: 0.50 Valid until: 09/03/2014 Claim your CME credit at http://www.reachmd.com/cmedetails.aspx?sid=6796</p><p>5-ASA agents as first-line therapy for patients with mild-to-moderate ulcerative colitis have demonstrated high rates of response and induction of remission, as well as displayed an excellent overall safety profile. Join our faculty as they discuss inducing and maintaining remission, differing treatment formulations, issues of adherence, and disease progression.</p> <p><strong>Estimated time to complete: </strong>30 minutes</p> <p>Share the <em>Ulcerative Colitis Weekly Tips</em> text messaging program with your patients. <br>Click the button below to download a flyer for your office.</p> <p align="center"><a href="http://www.provaeducation.com/downloads/UC_Text_Msg_Flyer_FNL1.pdf" target="_blank"><img src="http://www.provaeducation.com/images/prova_download_pdf.jpg" border="0"></a></p>